Skip to main content

Table 1 The results of laboratory test of the blood and the bronchoalveolar lavage fluid (BALF)

From: Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease

 

Case1

Case2

Blood examination

 WBC (/μL)

6,800

4,500

 CRP (mg/dL)

0.02

0.03

 LDH (IU/L)

222

202

 SP-D (ng/mL)

37

19.3

 KL-6 (IU/mL)

299

211

 β-D-glucan (pg/mL)

negative

negative

 CMV antigen pp65 C7-HRP (antigenemia)

negative

negative

BALF

 Fluid (mL)

17/100

23/150

 cell count (/mL)

4 × 105

1 × 105

 Lymphocyte (%)

54.5

17

 Neutrophil (%)

1

25

 Eosinophil (%)

5

1

 Basophil (%)

0

0

 Histiocyte (%)

39.5

57

 CD4/CD8 rate

1.2

0.65

culture

negative

negative

Arterial blood gas

 pH

7.396

NA

 PaO2 (mmHg)

36.0

NA

 PaCO2 (mmHg)

82.5

NA

 HCO3 - (mmol/L)

21.6

NA

 BE

−2.2

NA